Loading...
•
Sep 30, 2024
Merit Medical Q3 2024 Earnings Report
Merit Medical's Q3 2024 results were reported, with revenue up 7.8% and full-year guidance raised.
Key Takeaways
Merit Medical reported better-than-expected financial results in Q3 2024, with revenue increasing by 7.8% to $339.8 million. The company saw improvements in non-GAAP operating margin and non-GAAP EPS, and generated $120 million in free cash flow over the first nine months of 2024. Updated financial guidance for fiscal year 2024 reflects stronger-than-expected organic growth and profitability.
Reported revenue of $339.8 million, up 7.8%.
GAAP operating margin of 11.0%, compared to 11.1% in prior year period.
GAAP EPS $0.48, up 8.0%, and non-GAAP EPS $0.86, up 21.1%.
Completed the acquisition of certain assets from EndoGastric Solutions, Inc.
Merit Medical
Merit Medical
Forward Guidance
Merit Medical updated its fiscal year 2024 financial guidance to reflect the stronger-than-expected organic growth and profitability results to-date. The updated guidance continues to assume the forecasted impacts from the acquisition of EndoGastric Solutions and the projected impacts from the acquisition of assets from Cook Medical.